| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Ocular Molecular Genetics Institute, Massachusetts Eye and Ear Infirmary, Boston; the 2 Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida; 3 Schepens Retina Associates, Boston, Massachusetts; and the 4 Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
PURPOSE. To determine the spectrum of ABCR mutations associated with Stargardt macular degeneration and cone–rod degeneration (CRD).
METHODS. One hundred eighteen unrelated patients with recessive Stargardt macular degeneration and eight with recessive CRD were screened for mutations in ABCR (ABCA4) by single-strand conformation polymorphism analysis. Variants were characterized by direct genomic sequencing. Segregation analysis was performed on the families of 20 patients in whom at least two or more likely pathogenic sequence changes were identified.
RESULTS. The authors found 77 sequence changes likely to be pathogenic: 21 null mutations (15 novel), 55 missense changes (26 novel), and one deletion of a consensus glycosylation site (also novel). Fifty-two patients with Stargardt macular degeneration (44% of those screened) and five with CRD each had two of these sequence changes or were homozygous for one of them. Segregation analyses in the families of 19 of these patients were informative and revealed that the index cases and all available affected siblings were compound heterozygotes or homozygotes. The authors found one instance of an apparently de novo mutation, Ile824Thr, in a patient. Thirty-seven (31%) of the 118 patients with Stargardt disease and one with CRD had only one likely pathogenic sequence change. Twenty-nine patients with Stargardt disease (25%) and two with CRD had no identified sequence changes.
CONCLUSIONS. This report of 42 novel mutations brings the growing number of identified likely pathogenic sequence changes in ABCR to approximately 250.
This article has been cited by other articles:
|
|
 |
|
  J Aguirre-Lamban, R Riveiro-Alvarez, S Maia-Lopes, D Cantalapiedra, E Vallespin, A Avila-Fernandez, C Villaverde-Montero, M J Trujillo-Tiebas, C Ramos, and C Ayuso Molecular analysis of the ABCA4 gene for reliable detection of allelic variations in Spanish patients: identification of 21 novel variants Br. J. Ophthalmol., May 1, 2009; 93(5): 614 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Roberts, R. S. Ramesar, and J. Greenberg Clinical Utility of the ABCR400 Microarray: Basing a Genetic Service on a Commercial Gene Chip Arch Ophthalmol, April 1, 2009; 127(4): 549 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Cideciyan, M. Swider, T. S. Aleman, Y. Tsybovsky, S. B. Schwartz, E. A.M. Windsor, A. J. Roman, A. Sumaroka, J. D. Steinberg, S. G. Jacobson, et al. ABCA4 disease progression and a proposed strategy for gene therapy Hum. Mol. Genet., March 1, 2009; 18(5): 931 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Valverde, R. Riveiro-Alvarez, J. Aguirre-Lamban, M. Baiget, M. Carballo, G. Antinolo, J. M. Millan, B. G. Sandoval, and C. Ayuso Spectrum of the ABCA4 Gene Mutations Implicated in Severe Retinopathies in Spanish Patients Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 985 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Downs, D. N. Zacks, R. Caruso, A. J. Karoukis, K. Branham, B. M. Yashar, M. H. Haimann, K. Trzupek, M. Meltzer, D. Blain, et al. Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care Arch Ophthalmol, February 1, 2007; 125(2): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. A. Mandal, J. R. Heckenlively, T. Burch, L. Chen, V. Vasireddy, R. K. Koenekoop, P. A. Sieving, and R. Ayyagari Sequencing Arrays for Screening Multiple Genes Associated with Early-Onset Human Retinal Degenerations on a High-Throughput Platform Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3355 - 3362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stenirri, I. Fermo, S. Battistella, S. Galbiati, N. Soriani, R. Paroni, M. P. Manitto, E. Martina, R. Brancato, R. Allikmets, et al. Denaturing HPLC Profiling of the ABCA4 Gene for Reliable Detection of Allelic Variations Clin. Chem., August 1, 2004; 50(8): 1336 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. K. Derwent, D. J. Derlacki, J. R. Hetling, G. A. Fishman, D. G. Birch, S. Grover, E. M. Stone, and D. R. Pepperberg Dark Adaptation of Rod Photoreceptors in Normal Subjects, and in Patients with Stargardt Disease and an ABCA4 Mutation Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2447 - 2456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. September, A. A. Vorster, R. S. Ramesar, and L. J. Greenberg Mutation Spectrum and Founder Chromosomes for the ABCA4 Gene in South African Patients with Stargardt Disease Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1705 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fukui, S. Yamamoto, K. Nakano, M. Tsujikawa, H. Morimura, K. Nishida, N. Ohguro, T. Fujikado, M. Irifune, K. Kuniyoshi, et al. ABCA4 Gene Mutations in Japanese Patients with Stargardt Disease and Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2819 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Suarez, S. B. Biswas, and E. E. Biswas Biochemical Defects in Retina-specific Human ATP Binding Cassette Transporter Nucleotide Binding Domain 1 Mutants Associated with Macular Degeneration J. Biol. Chem., June 7, 2002; 277(24): 21759 - 21767. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
